1.. INTRODUCTION
================

Infection with high-risk (oncogenic) types of human papillomavirus (HPV) is a well-established risk factor for the development of cervical carcinoma \[[@R1]\]. Association between HPV and the development of certain head and neck cancers has also been established recently \[[@R2]\]. This is strengthened by the fact that the oncogenic HPV types detected in cervical carcinomas have also been identified in head and neck cancers \[[@R3]\].

The use of nested polymerase chain reaction (PCR) employing degenerate consensus primers has been shown by various authors to be an extremely sensitive method for detecting a wide range of known and novel HPV types \[[@R4], [@R5]\]. Previous studies, including our own work, have found MY/GP two-step nested PCR to be far more sensitive than the USFDA approved Hybrid Capture II assay (Digene), for detecting HPV \[[@R6]-[@R8]\].

A two-step or two-tube nested PCR is time-consuming, requires two sets of reaction mixtures and is prone to false positive reactions, as transfer from first to second amplification reaction can result in cross-contamination \[[@R9]\]. On the other hand, single-tube/step nested PCR requires only a single preparation of reaction mixture thus reducing the risk of contamination and overall reaction time. However, single-tube nested PCR incorporating two primer pairs could lead to cross-reactivity among the outer and inner set of primers leading to non-specific bands. Instead of conventional four primers in nested PCR assay, some researchers use only three primers \[[@R10], [@R11]\], whereby one outer primer is shared with two inner primers, and categorize it as seminested PCR. Seminested PCRs often help in reducing undesired products, while at the same time dramatically increasing sensitivity. Use of three or more primers in a single tube to perform seminested PCR, by changing concentration of DNA and annealing temperatures for detection of virus and bacteria had been reported, although these studies were not designed for HPV detection. Previous seminested PCRs developed for HPV detection were performed as two-tube seminested \[[@R10]-[@R12]\]. This study aimed to develop a single-tube seminested PCR method for HPV DNA detection.

2.. MATERIALS AND METHODOLOGY
=============================

2.1.. Selection of Primers for Single-Tube Seminested PCR
---------------------------------------------------------

Primers specific for L1 region of the HPV genome namely MY09, MY11 and GP6+ (Fig. **[1](#F1){ref-type="fig"}**) were employed in this study \[[@R13], [@R14]\]. A mixture of plasmids with HPV DNA inserts of type 6,11,16,18,31,33,38 and 51 were utilized as templates in the PCR.

2.2.. Optimization of Single-Tube Seminested PCR
------------------------------------------------

Optimization of the PCR was done on several parameters such as annealing temperatures of MY09/11 and MY11/ GP6+ primer pairs, concentration of MY09,11 and GP6+ primers, MgCl~2~, *Taq* polymerase and number of cycles for first and second round PCR, to obtain best results with HPV plasmid DNA.

2.3.. HPV Detection by Single-Tube Seminested PCR
-------------------------------------------------

For this assay optimized amounts of reagents (primers MY09, MY11, GP6+; MgCl~2~; *Taq* polymerase), dNTPs, buffer and sample DNA were made up to 20 µl total reaction volume. PCR was performed at optimized annealing temperatures and number of cycles on HPV plasmid mix. Sensitivity of the assay was also determined.

2.4.. HPV Detection by Two-Tube Nested PCR
------------------------------------------

Two-tube PCR was performed on HPV plasmids as above using conditions as per the published literature \[[@R7], [@R15]\].

2.5.. Clinical Samples
----------------------

Informed consent was obtained from the participants before proceeding for sample collection. The study was approved by Human Research and Ethics Committee, Universiti Sains Malaysia (FWA Reg. No: 007718).

### 2.5.1.. Cervical Samples

Cervical scrapings from 30 patients were obtained from Obstetrics and Gynecology clinics of Hospital Universiti Sains Malaysia (Table **[1](#T1){ref-type="table"}**). Two swabs were obtained using cytobrush. One of the swabs was used in the preparation of Pap smear for evaluation by pathologists based on Bethesda reporting system, 2001 \[[@R16]\] while the other was stored in -20^o^C freezer for further analysis.

### 2.5.2.. Oral Samples

Buccal swabs from 30 head and neck cancer patients were collected using sterile EUROTUBO^®^ collection swabs (Table **[2](#T2){ref-type="table"}**). The swab was held against the buccal mucosa and rubbed for 10 seconds at each side and stored in -20^o^C freezer until further analysis.

2.6.. DNA Extraction and HPV Detection in Clinical Samples
----------------------------------------------------------

DNA was extracted from samples with the QIAamp^®^DNA Extraction Mini Kit (Qiagen, Germany) according to the manufacturer's protocol. To check the quality of DNA samples, a 268-base-pair sequence of β-globin gene was amplified as an internal control. PCR was performed on all clinical samples with optimized single-tube seminested and two-tube nested PCR to evaluate its clinical performance.

3.. RESULTS AND DISCUSSION
==========================

3.1.. Establishment and Optimization of Single-Tube Seminested PCR
------------------------------------------------------------------

To begin with, MY11/GP6+ PCR was performed in 20 µl total reaction volume with 100pg of plasmid DNA template using conditions described in previously published literature for MY 09/11 and GP5+/6+ systems \[[@R17]\]. A single 190bp band was visualized as PCR product.

To obtain this 190bp amplicon in single-tube seminested PCR, optimization with primers MY09, MY11 and GP6+ was done. To allow for the difference in annealing temperatures, the melting temperatures (*Tm*s) of outer and inner primer pairs were established more than 10°C apart. The highest amplification was observed at 53.0°C & 40.0°C for MY09/11 and MY11/GP6+ primer pairs respectively. The substantially higher first round annealing temperature (53°C) prevented the second round primers annealing to the template DNA until the temperature was reduced to 40.0°C at the start of the second round of amplification.

The optimization for the primer concentration was done by varying the concentration of one primer, keeping the other two primer concentrations fixed. As the concentration of MY09 was decreased, the 450bp band became less visible and was replaced by a 190 bp band at 1 pmole of MY09 primer (Fig. **[2](#F2){ref-type="fig"}**). A concentration of 2.5 pmole for other outer primer MY09 was sufficient for optimum product formation in both amplification rounds of seminested PCR. Concentration of MY09 lower than 2.5 pmole resulted in only one band of 190 bp signifying that its concentration was too low to give any product to be used as a template for MY11/GP6+ primers. A concentration higher than 2.5 pmole for MY09 also gave only one band which was of 450 bp, indicating that no MY11/GP6+ product formation occurred.

Different combinations of number of cycles were used, i.e. 5 and 30, 10 and 30, 20 and 30, 20 and 20, 30 and 30, for first and second round PCR respectively, to determine the optimum number of cycles. An increase in the first round of PCR cycles resulted in a strong MY09/11 band (450 bp) while an increase in second round cycles resulted in a strong MY11/GP6+ band (190 bp). In order to achieve clearly detectable amplification of the 190 bp product in the shortest overall time without any nonspecific bands, PCR with 10 cycles in the first round followed by 30 cycles for the second round was found to provide the best results.

As a result of optimizing PCR parameters, conditions for amplification were as follows: 1.5 mM MgCl~2~, 200 mM dNTP mixture, 10 pmol of MY11 and GP6+ primers, 2.5 pmol of MY09 primer, and 1 U of hot start *Taq* polymerase (Fermentas) per 20 µl of the reaction mixture. Initial denaturation occurred at 95°C for 3 min, followed by 10 cycles of 95°C for 30 s, 53°C for 30 s, and 72°C for 30 s. This was followed by another 30 cycles of 95°C for 30 s, 40°C for 30 s, and 72°C for 30 s. A final extension was done at 72°C for 7 min.

3.2.. Evaluation of Single-Tube and Two-Tube PCR on HPV Plasmids
----------------------------------------------------------------

The optimized single-tube seminested PCR performed on plasmids with different HPV genotype inserts produced amplicons of either 190 bp or 450 bp or both (Fig **[3A](#F3){ref-type="fig"}**). Results for two-tube nested PCR are shown in Fig **[3B](#F3){ref-type="fig"}**. The identity of the bands was further confirmed to be that of the HPV-L1 region by sequencing (data not shown). The results of single-tube seminested were comparable with that of two-tube nested using plasmids with HPV genotype inserts.

Figs. (**[4A](#F4){ref-type="fig"}** and **[4B](#F4){ref-type="fig"}**) show the sensitivity of single-tube seminested PCR and two-tube nested PCR. The detection limit for seminested PCR was also found to have a comparable sensitivity up to a concentration of 1 fg of HPV DNA. Two-tube nested PCR gave brightest band at 10 pg, which suggests that excessive DNA template available at the start of second round of GP nested PCR might inhibit the PCR reaction resulting in false negative results. Furthermore, two-tube nested PCR gave amplicons at 140, 190 and 450 bp due to cross-reaction between different primers. No such cross-reactivity was seen with single-tube seminested PCR.

3.3.. Evaluation of Single-Tube and Two-Tube PCR on Clinical Samples
--------------------------------------------------------------------

The results of HPV DNA detection in the cervical scrapings and buccal swabs by single-tube seminested and two-tube nested PCR are shown in Table **[1](#T1){ref-type="table"}** and Table **[2](#T2){ref-type="table"}** respectively. The results of our assay were comparable with that of two-tube nested PCR. Nineteen cervical swabs (63.3%) and 17 buccal swabs (56.7%) were found to be positive for HPV by single-tube PCR. With two-tube, 18 cervical samples (60%) and 19 buccal samples (63.3%) were positive for HPV. Analysis of the quality of DNA of the two buccal swabs positive by two-tube but negative by single-tube assay revealed low concentration of DNA as compared to other samples. The higher positivity in two-tube could also have been due to false positivity by cross contamination during nested step. In the cervical samples, the concentration of one discordant sample was relatively high as compared to other samples which may have resulted in a false negative result seen in the two-tube assay as explained above. This was a preliminary clinical evaluation of the assay we developed using a relatively small number of samples. We intend to carry out further assessment on more samples to better evaluate the single-tube seminested assay.

In this study, we have described an improved nested amplification system for HPV in which the reagents of both PCR rounds were included in a single tube to eliminate the risk of contamination in two-tube PCR at the nesting step. Further, as designing a system with short final amplification products greatly increases its amplification efficiency \[[@R18]\]; single-tube seminested gave the final amplification product of 190 bp which was less than half the size of MY09-MY11 product.

4.. CONCLUSION
==============

Single-tube seminested PCR was developed and evaluated for the detection of HPV DNA in plasmids with HPV inserts and clinical samples. Preliminary results show that our assay appears to be well suited for detecting HPV in cervical as well as buccal swabs. Further evaluation using larger number of samples is in progress. As this method is rapid, highly sensitive and has minimum cross contamination, it has a potential in screening high-risk patients and epidemiological studies.
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![Diagrammatic representation of the locations of MY09/11, GP5+/6+ general primer sets on L1 region of HPV genome. The expected amplicon size for each of the primer set is indicated.](TOMICROJ-3-106_F1){#F1}

![PCR products of optimization of MY09 primer concentration run on 2% agarose gel. Primer at various concentrations \[pmol\], lanes 1-9. M = 100bp DNA marker, lane1 = 10.0, 2 = 7.5, 3 = 5.0, 4 = 2.5, 5 = 1.0, 6 = 0.5, 7 = 0.1, 8 = 0.05, 9 = 0.01.](TOMICROJ-3-106_F2){#F2}

![Evaluation of single-tube seminested and two-tube nested PCRs on HPV plasmids of genotypes 6,11,16,18,31,33,38 and 51. **A:** Single tube seminested PCR products with amplicons of 450 bp and/or 190 bp. **B:** Two-tube nested PCR wıth amplicons of 140bp after second round PCR. Non-specific bands are also visible.](TOMICROJ-3-106_F3){#F3}

![Detection limits for single-tube seminested and two-tube nested PCR when tested on pooled HPV plasmid DNA. **A:** PCR products for single-tube seminested showing detection sensitivity of up to 1 fg HPV DNA. **B:** PCR products for two-tube nested, after second PCR step showing same detection sensitivity.](TOMICROJ-3-106_F4){#F4}

###### 

Detection of HPV in the Cervical Scrapings of Clinically Suspected Patients by Two-Tube Nested and Single-Tube Seminested PCR

  Case no.   Diagnosis   Age   Two-Tube Nested PCR   Single-Tube Seminested PCR
  ---------- ----------- ----- --------------------- ----------------------------
  1          Normal      36    \-                    \-
  2          CIN1        54    \+                    \+
  3          Normal      60    \+                    \+
  4          Normal      31    \+                    \+
  5          CIN1        48    \+                    \+
  6          Normal      40    \-                    \-
  7          STD         42    \+                    \+
  8          CIN1        62    \+                    \+
  9          Normal      39    \-                    \-
  10         Normal      51    \+                    \+
  11         Normal      42    \-                    \-
  12         CIN1        39    \+                    \+
  13         CIN1        62    \+                    \+
  14         STD         36    \+                    \+
  15         STD         41    \+                    \+
  16         Normal      41    \-                    \-
  17         Normal      46    \+                    \+
  18         Normal      48    \+                    \+
  19         CIN1        57    \-                    \-
  20         Normal      50    \+                    \+
  21         CIN2        64    \+                    \+
  22         Normal      58    \-                    \-
  23         Normal      61    \-                    \-
  24         STD         40    \+                    \+
  25         CIN1        46    \+                    \+
  26         Normal      35    \-                    \-
  27         STD         38    \+                    \+
  28         Normal      49    \-                    \-
  29         CIN2        53    \-                    \+
  30         Normal      41    \-                    \-

CIN 1=Cervical Intraepithelial Neoplasia Grade I; CIN2=Cervical Intraepithelial Neoplasia Grade II; STD=Sexually transmitted disease; +=positive; -=negative.

###### 

Detection of HPV in the Buccal Swabs of Head and Neck Cancer Patients by Two-Tube Nested and Single-Tube Seminested PCR

  Case no.   Diagnosis               Stage   Age   Sex   Two-Tube Nested   Single-Tube Seminested
  ---------- ----------------------- ------- ----- ----- ----------------- ------------------------
  1          Laryngeal cancer        IV      69    F     \-                \-
  2          Nasopharyngeal cancer   IV      33    M     \+                \-
  3          Oral cancer             II      47    M     \-                \-
  4          Tonsillar cancer        IV      73    F     \+                \+
  5          Oral cancer             IV      53    M     \-                \-
  6          Nasopharyngeal cancer   IV      59    M     \+                \+
  7          Oral cancer             III     53    M     \+                \+
  8          Nasopharyngeal cancer   I       51    F     \-                \-
  9          Parotid Gland cancer    NA      59    F     \-                \-
  10         Laryngeal cancer        IV      73    M     \+                \+
  11         Nasopharyngeal cancer   IV      53    F     \+                \-
  12         Nasopharyngeal cancer   IV      28    F     \+                \+
  13         Nasopharyngeal cancer   IV      50    F     \+                \+
  14         Nasopharyngeal cancer   IV      55    F     \+                \+
  15         Nasopharyngeal cancer   IV      57    M     \+                \+
  16         Nasopharyngeal cancer   IV      67    M     \-                \-
  17         Nasopharyngeal cancer   IV      19    M     \+                \+
  18         Nasopharyngeal cancer   IV      58    M     \-                \-
  19         Oral cancer             II      71    M     \+                \+
  20         Nasopharyngeal Cancer   IV      71    M     \-                \-
  21         Nasopharyngeal cancer   IV      47    M     \+                \+
  22         Laryngeal cancer        I       39    F     \-                \-
  23         Nasopharyngeal cancer   IV      60    M     \-                \-
  24         Oral cancer             IV      69    F     \+                \+
  25         Nasopharyngeal cancer   IV      30    M     \+                \+
  26         Tonsillar cancer        IV      58    F     \+                \+
  27         Oropharyngeal cancer    IV      75    M     \+                \+
  28         Nasopharyngeal cancer   IV      32    M     \+                \+
  29         Sinonasal cancer        NA      65    F     \+                \+
  30         Sinonasal cancer        NA      53          \-                \-

+= positive; -= negative. NA = not available.
